Rep. David Taylor Buys Lam Research Corporation (NASDAQ:LRCX) Stock

Representative David Taylor (Republican-Ohio) recently bought shares of Lam Research Corporation (NASDAQ:LRCX). In a filing disclosed on March 20th, the Representative disclosed that they had bought between $1,001 and $15,000 in Lam Research stock on March 12th. The trade occurred in the Representative’s “DAVID TAYLOR TRUST > SARDINIA READY MIX 401(K) – DAVE” account.

Representative David Taylor also recently made the following trade(s):

  • Sold $1,001 – $15,000 in shares of Chevron (NYSE:CVX) on 3/12/2026.
  • Purchased $1,001 – $15,000 in shares of Installed Building Products (NYSE:IBP) on 3/12/2026.
  • Purchased $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 3/12/2026.
  • Purchased $1,001 – $15,000 in shares of RPM International (NYSE:RPM) on 3/12/2026.
  • Purchased $1,001 – $15,000 in shares of Parker-Hannifin (NYSE:PH) on 3/12/2026.
  • Sold $1,001 – $15,000 in shares of Marathon Petroleum (NYSE:MPC) on 3/11/2026.
  • Purchased $1,001 – $15,000 in shares of Fifth Third Bancorp (NASDAQ:FITB) on 3/11/2026.
  • Sold $1,001 – $15,000 in shares of Chevron (NYSE:CVX) on 3/11/2026.
  • Purchased $1,001 – $15,000 in shares of RPM International (NYSE:RPM) on 3/11/2026.
  • Purchased $1,001 – $15,000 in shares of Visa (NYSE:V) on 2/26/2026.

Lam Research Price Performance

Shares of NASDAQ LRCX opened at $233.31 on Tuesday. Lam Research Corporation has a 1-year low of $56.32 and a 1-year high of $256.68. The business has a 50-day moving average of $227.18 and a 200-day moving average of $179.07. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.26 and a quick ratio of 1.61. The company has a market capitalization of $291.35 billion, a price-to-earnings ratio of 47.81, a PEG ratio of 2.46 and a beta of 1.77.

Lam Research (NASDAQ:LRCXGet Free Report) last announced its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 EPS for the quarter, beating the consensus estimate of $1.17 by $0.10. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The business had revenue of $5.34 billion for the quarter, compared to the consensus estimate of $5.23 billion. During the same period last year, the business posted $0.91 EPS. The company’s revenue was up 22.1% on a year-over-year basis. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. On average, equities analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Shareholders of record on Wednesday, March 4th will be paid a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date is Wednesday, March 4th. Lam Research’s payout ratio is currently 21.31%.

Insider Activity at Lam Research

In related news, insider Ava Harter sold 1,500 shares of the firm’s stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $222.66, for a total transaction of $333,990.00. Following the completion of the transaction, the insider directly owned 53,205 shares of the company’s stock, valued at $11,846,625.30. This trade represents a 2.74% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Eric Brandt sold 35,000 shares of Lam Research stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $225.60, for a total value of $7,896,000.00. Following the transaction, the director directly owned 253,705 shares in the company, valued at $57,235,848. The trade was a 12.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 130,886 shares of company stock worth $29,658,802 over the last three months. Company insiders own 0.31% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. PMV Capital Advisers LLC acquired a new stake in Lam Research during the 4th quarter worth approximately $25,000. Stance Capital LLC acquired a new position in Lam Research in the 3rd quarter valued at approximately $26,000. Bayban bought a new position in shares of Lam Research during the fourth quarter valued at $26,000. Howard Hughes Medical Institute bought a new position in shares of Lam Research during the second quarter valued at $27,000. Finally, Triumph Capital Management acquired a new position in shares of Lam Research during the third quarter worth $27,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

LRCX has been the subject of a number of analyst reports. Morgan Stanley upped their price objective on shares of Lam Research from $244.00 to $254.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 25th. Zacks Research upgraded Lam Research from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 20th. The Goldman Sachs Group set a $262.00 target price on Lam Research and gave the company a “buy” rating in a research note on Thursday, January 29th. JPMorgan Chase & Co. raised their price target on shares of Lam Research from $165.00 to $300.00 and gave the stock an “overweight” rating in a research report on Thursday, January 29th. Finally, Stifel Nicolaus lifted their price target on shares of Lam Research from $250.00 to $280.00 and gave the stock a “buy” rating in a research note on Thursday, January 29th. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $245.35.

Read Our Latest Research Report on LRCX

About Representative Taylor

David Taylor (Republican Party) is a member of the U.S. House, representing Ohio’s 2nd Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Taylor (Republican Party) ran for election to the U.S. House to represent Ohio’s 2nd Congressional District. He won in the general election on November 5, 2024.

David Taylor graduated from Amelia High School. Taylor earned degrees from Miami University (Ohio) and the University of Dayton School of Law. Taylor’s career experience includes working as an attorney and as a businessman at Sardinia Ready Mix, Inc.

Lam Research Company Profile

(Get Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Read More

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.